News Novo Nordisk A/S Sao Paulo

Equities

N1VO34

BRN1VOBDR005

Market Closed - Sao Paulo Other stock markets 01:15:17 26/06/2024 am IST			5-day change	1st Jan Change
99.98 ^BRL	+23.89%		+4.65%	+60.04%

25/06	Health Care Up as Novo Nordisk Gets China OK -- Health Care Roundup	DJ
25/06	Trending : Novo Nordisk's Wegovy Weight-Loss Drug Gets Chinese Approval	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Up as Novo Nordisk Gets China OK -- Health Care Roundup	26/06	DJ
Trending : Novo Nordisk's Wegovy Weight-Loss Drug Gets Chinese Approval	26/06	DJ
Sector Update: Health Care Stocks Easing Tuesday Afternoon	25/06	MT
Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls	25/06	MT
European Equities Close Lower in Tuesday Trading; EC Accuses Microsoft of Breaking Antitrust Laws	25/06	MT
MEDIA-Novo weight-loss drug Saxenda poses risk to bone health, study finds - Bloomberg News	25/06	RE
Market Update-Europe closes lower in a session marked by a wait-and-see attitude	25/06	RE
European Equities Traded in the US as American Depositary Receipts Nudge Higher Tuesday Trading	25/06	MT
Novo Nordisk Wins Weight-Loss Drug Approval in China; Plans $4.1 Billion US Facility	25/06	MT
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla...	25/06
Sector Update: Health Care Stocks Advance Pre-Bell Tuesday	25/06	MT
Sector Update: Health Care	25/06	MT
Exchange-Traded Funds Edge Higher, Equity Futures Mixed Pre-Bell Tuesday Ahead of Upcoming Economic Reports	25/06	MT
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	25/06	MT
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	25/06	DJ
European Midday Briefing : Stocks Dented by U.S. Tech, Airbus Warning	25/06	DJ
NOVO NORDISK : Deutsche Bank remains its Buy rating	25/06	ZD
Novo Nordisk says its Wegovy weight-loss drug wins China approval	25/06	RE
Novo Nordisk: new plant project in North Carolina	25/06	CF
Europe in the red with tech and political risk	25/06	RE